Ordinary Adjustment | Solactive Global Vaccines and Infectious Diseases Index | Effective Date 17th February 2026
Solactive Global Vaccines and Infectious Diseases Index:
In the ordinary adjustment, the following composition will be implemented effective open 17th February 2026:
| ABCELLERA BIOLOGICS INC |
| ADMA BIOLOGICS INC |
| ASTRAZENECA PLC |
| BAVARIAN NORDIC A/S |
| BIONTECH SE |
| BRISTOL-MYERS SQUIBB CO |
| CAPRICOR THERAPEUTICS INC |
| CSL LTD ORD |
| DENKA CO LTD |
| DYNAVAX TECHNOLOGIES CORP |
| GILEAD SCIENCES INC |
| GREEN CROSS CORP ORD |
| GSK PLC |
| IMMUNITYBIO INC |
| JOHNSON & JOHNSON |
| LIVZON PHARMACEUTICAL GROUP INC |
| MERCK & CO. INC. |
| MODERNA INC |
| NOVAVAX INC |
| OPKO HEALTH INC |
| PFIZER INC |
| QUIDELORTHO CORPORATION |
| REGENERON PHARMACEUTICALS |
| SANOFI SA |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
| SK BIOSCIENCE ORD |
| TG THERAPEUTICS INC |
| VAXCYTE INC |
| VIR BIOTECHNOLOGY INC |
| ZOETIS INC |